Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment

Abstract

Objective Clinical response to antipsychotic drug treatment is highly variable, yet prognostic biomarkers are lacking. The authors recently demonstrated that successful antipsychotic drug treatment alters resting-state functional connectivity of the striatum. The goal of the present study was to test whether intrinsic striatal connectivity patterns provide prognostic information and can serve as a potential biomarker of treatment response to antipsychotic drugs. Method The authors used resting-state functional MRI (fMRI) to develop a prognostic index in a discovery cohort of 41 first-episode schizophrenia patients, then tested this index in an independent cohort of 40 newly hospitalized chronic patients with acute psychosis. In the discovery cohort, patients underwent resting-state fMRI scanning at the initiation of randomized controlled treatment with a second-generation antipsychotic. Whole-brain functional connectivity maps were generated for each subject from striatal seed regions. A stringent measure of clinical response was calculated that required sustained improvement over two consecutive study visits. Clinical response was entered into a survival analysis, and Cox regression was applied to the functional connectivity data. A striatal connectivity index was created, comprising functional connections of the striatum that predicted treatment response. This striatal connectivity index was tested on a generalizability cohort of patients with psychotic disorders who were hospitalized for an acute psychotic episode. Results A total of 91 regions functionally connected with the striatum provided significant prognostic information. Connectivity in these regions was used to create a baseline striatal connectivity index that predicted response to antipsychotic treatment with high sensitivity and specificity in both the discovery and generalizability cohorts. Conclusions These results provide evidence that individual differences in striatal functional connectivity predict response to antipsychotic drug treatment in acutely psychotic patients. With further development, this has the potential to serve as a prognostic biomarker with clinical utility and to reduce the overall burden associated with psychotic illnesses.

Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review

“…Investigating neurochemical differences between treatment-responsive and treatment-resistant patients may be of particular importance, as these could inform different approaches to pharmacological intervention. Neuroimaging studies may also use resting state data to investigate functional connectivity, as a recent study [84] and a review of the broader literature [48] have indicated this may have a role in predicting treatment response. In terms of genetic markers of treatment-resistant illness, psychiatric genetics as a field has moved away from the candidate-gene approach used in all genetic studies identified by the present review; future research should consider instead well-powered GWAS’s and more sophisticated models incorporating gene-environment interactions and epigenetic variation.…”

Converging effects of diverse treatment modalities on frontal cortex in schizophrenia: A review of longitudinal functional magnetic resonance imaging studies

“…We excluded two APM papers (35, 36) due to the lack of meaningfully defined pre-treatment conditions (too diverse a representation of APM's), which make interpretation of the results difficult. We excluded investigations evaluating: 1) the effects of one session of cognitive training on brain function (not longitudinal) (37) and 2) baseline functional abnormalities in patients which predicted treatment outcome (38-40). (See Figure 1 for details regarding literature search and study selection).…”

Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action

“…Further, there is evidence that functional connectivity may predict response to treatment with antipsychotics (Sarpal et al, 2016) and that functional connectivity changes are correlated with alleviation of symptoms following successful treatment (Sarpal et al, 2015). …”